Brind.

Fortrea was spun off from Labcorp in 2023.

4 reports, 2 independent Updated Jun 30
Gone quiet
Reports
4
Developments
1
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Fortrea was spun off from Labcorp in 2023.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • yahoo.com
  • StockStoryReflecting On Drug Development Inputs & Services Stocks’ Q2 Earnings: Fortrea (NASDAQ:FTRE) Looking back on drug development inputs & services stocks’ Q2 earnings, we examine this quarter’s best and
  • StockStoryFortrea (NASDAQ:FTRE) Reports Bullish Q2, Stock Soars Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2025 results exceeding the market’s revenue expectations , with sales up 7
  • StockStory2 Unpopular Stocks That Deserve Some Love and 1 Facing Challenges Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typical